Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | ETX-929 |
| Trade Name | |
| Synonyms | ETX929|ETX 929 |
| Drug Descriptions |
ETX-929 inhibits KRAS in both GTP- and GDP-bound states, with activity against KRAS mutants including G12C, G12V, and Q61H, which potentially decreases KRAS signaling and tumor cell proliferation (Cancer Res (2026) 86 (7_Supplement): 418). |
| DrugClasses | KRAS Inhibitor 35 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cetuximab + ETX-929 | Cetuximab ETX-929 | 0 | 1 |
| ETX-929 | ETX-929 | 0 | 1 |